Haptoglobin and Preeclampsia
NCT01027130 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-12-07
Summary
The purpose of this study is to show that a certain protein called haptoglobin protects against preeclampsia which is a common pregnancy complication.
Conditions
Sponsors & Collaborators
-
Bnai Zion Medical Center
lead OTHER_GOV
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
The Role of Pro-angiogenic Immune Cells in Human Pregnancies
NCT01177020 ·Status: UNKNOWN
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
NCT01068002 ·Status: COMPLETED
-
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia
NCT06712550 ·Status: COMPLETED
-
Relation Between Protein 13 and Gestational Hypertensive Disorder
NCT05517512 ·Status: COMPLETED
-
Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers
NCT04833881 ·Status: UNKNOWN
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
NCT03735108 ·Status: UNKNOWN
-
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
NCT03567551 ·Status: COMPLETED
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Hyperspectral Imaging for Prediction of Preeclampsia
NCT07106294 ·Status: RECRUITING
-
Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery
NCT01404910 ·Status: COMPLETED ·Phase: NA
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Cardiovascular Changes in Infants of Preeclampsia Mother
NCT04699825 ·Status: UNKNOWN ·Phase: NA
-
New Therapeutic Strategy Against Preeclampsia
NCT06464159 ·Status: RECRUITING
-
Agouti-related Peptide (AgRP) in Healthy Mothers and Mothers With Preeclampsia and Their Offspring
NCT01042210 ·Status: COMPLETED
-
Disease Modification in Toxaemia of Pregnancy
NCT00175695 ·Status: COMPLETED
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero
NCT05091827 ·Status: UNKNOWN
-
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia
NCT03149250 ·Status: UNKNOWN
-
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070 ·Status: RECRUITING
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Cardiovascular Risk After Preeclampsia
NCT05277233 ·Status: RECRUITING
-
Blood Loss and Preeclampsia
NCT04777097 ·Status: RECRUITING
-
Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
NCT01804751 ·Status: UNKNOWN